6V52
IDO1 IN COMPLEX WITH COMPOUND 1
Summary for 6V52
Entry DOI | 10.2210/pdb6v52/pdb |
Descriptor | Indoleamine 2,3-dioxygenase 1, 3-chloro-N-{4-[1-(propylcarbamoyl)cyclobutyl]phenyl}benzamide (3 entities in total) |
Functional Keywords | indoleamine dioxygenase, heme, inhibitor, oxidoreductase |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 2 |
Total formula weight | 89451.95 |
Authors | Lesburg, C.A.,Koenig, K.V.,Augustin, M.A. (deposition date: 2019-12-03, release date: 2020-04-08, Last modification date: 2020-04-29) |
Primary citation | White, C.,McGowan, M.A.,Zhou, H.,Sciammetta, N.,Fradera, X.,Lim, J.,Joshi, E.M.,Andrews, C.,Nickbarg, E.B.,Cowley, P.,Trewick, S.,Augustin, M.,von Koenig, K.,Lesburg, C.A.,Otte, K.,Knemeyer, I.,Woo, H.,Yu, W.,Cheng, M.,Spacciapoli, P.,Geda, P.,Song, X.,Smotrov, N.,Curran, P.,Heo, M.R.,Abeywickrema, P.,Miller, J.R.,Bennett, D.J.,Han, Y. Strategic Incorporation of Polarity in Heme-Displacing Inhibitors of Indoleamine-2,3-dioxygenase-1 (IDO1). Acs Med.Chem.Lett., 11:550-557, 2020 Cited by PubMed: 32292563DOI: 10.1021/acsmedchemlett.0c00010 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.78 Å) |
Structure validation
Download full validation report